Redefining Cancer Care –
Tailor-made therapies to improve each patient’s quality of life.
At YGION, we envision a future where each cancer patient receives a bespoke therapy designed to fit their unique disease profile.
This approach maximizes effectiveness and minimizes side effects, paving the way for enhanced patient outcomes and better quality of life.
Target. Activate. Eradicate.
Eliminating cancer with tailor-made precision
By triggering a customized, tumor-specific immune response and harnessing the power of each patient’s own immune system, we aim to empower it to identify and destroy tumor cells.
NEWS
7th International Neoantigen Summit
YGION Biomedical’s team is attending the 7th International Neoantigen Summit from April 29 – May 1, in Amsterdam, Netherlands. This meeting unites the international neoantigen community to overcome neoantigen identification, prediction, and … read more
YGION Biomedical announces €15 Million Series A Financing to develop Individualized Cancer Immunotherapies
YGION Biomedical GmbH, a company dedicated to developing individualized neoantigen-based cancer vaccines, today announced the completion of a Series A financing round of €15 million from an Austrian private trust. The … read more
YGION Biomedical Awarded Grant from the Austrian Research Promotion Agency to develop Individualized Cancer Immunotherapies
YGION Biomedical GmbH, a company dedicated to developing individualized neoantigen-based cancer immunotherapies, today announces further fundraising news with the award of a significant Life Sciences grant from the … read more
